Lela Buckingham to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Lela Buckingham has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.044
-
A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation. Oncologist. 2021 10; 26(10):811-817.
Score: 0.044